Toulouse White Biotech (TWB) has partnered with process developer Processium and industrial synbio start-up Syngulon.
With the new partnerships, TWB will optimise projects led by hosted startups and industry partners. Processium specialises in technical and economic studies that validate the viability of a project, from the R&D phase to the production stage. Finally, Syngulon’s expertise allows it to boost the productivity of microbial production strains in an industrial production environment.
“After having partnered with Altar and iMEAN in 2020, TWB continues to diversify its service offering with Processium and Syngulon. Their expertise will accelerate the development of sustainable and innovative solutions and facilitate the development of bioprocesses, from the research stage to industrialisation” said Olivier Rolland, Executive Director of TWB.
The studies made by Processium aim for a purification process “for a target molecule resulting from bioproduction and to estimate the production costs of a complete process” according to the European Biotechnology magazine. “They allow us to detect the conditions of technical and economic viability on an industrial scale, to identify the parameters having the most impact on the production costs and to help in the decision-making on the roadmap to follow for the development of the project. By intervening from the very beginning of a project, Processium allows to strategically articulate the R&D actions and to optimise the development time and costs” says the magazine.
“TWB has extensive expertise in fermentation and genetic engineering. Our expertise in process engineering is complementary and covers other aspects of a project: production costs, waste treatment, environmental impact, etc. Our long-term vision and the technical and economic evaluation of bioprocesses allow us to identify very early on the conditions of viability of a project on an industrial scale”, said Pascal Rousseaux, CEO of Processium.